##gff-version 3
##sequence-region Q96EY5 1 273
Q96EY5	UniProtKB	Chain	1	273	.	.	.	ID=PRO_0000249069;Note=Multivesicular body subunit 12A	
Q96EY5	UniProtKB	Domain	9	151	.	.	.	Note=MABP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00831	
Q96EY5	UniProtKB	Domain	215	265	.	.	.	Note=UMA;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00830	
Q96EY5	UniProtKB	Region	192	273	.	.	.	Note=Interaction with TSG101%2C VPS37B and VPS28;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18005716;Dbxref=PMID:18005716	
Q96EY5	UniProtKB	Motif	155	160	.	.	.	Note=SH3-binding	
Q96EY5	UniProtKB	Modified residue	130	130	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18005716;Dbxref=PMID:18005716	
Q96EY5	UniProtKB	Modified residue	163	163	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18005716;Dbxref=PMID:18005716	
Q96EY5	UniProtKB	Modified residue	170	170	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:18005716;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163,PMID:18005716	
Q96EY5	UniProtKB	Modified residue	195	195	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q96EY5	UniProtKB	Modified residue	202	202	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q96EY5	UniProtKB	Modified residue	204	204	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16895919;Dbxref=PMID:16895919	
Q96EY5	UniProtKB	Modified residue	207	207	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18005716;Dbxref=PMID:18005716	
Q96EY5	UniProtKB	Modified residue	232	232	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18005716;Dbxref=PMID:18005716	
Q96EY5	UniProtKB	Alternative sequence	139	178	.	.	.	ID=VSP_020629;Note=In isoform 2. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96EY5	UniProtKB	Alternative sequence	238	253	.	.	.	ID=VSP_020630;Note=In isoform 3. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96EY5	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_049018;Note=C->Y;Dbxref=dbSNP:rs34949802	
Q96EY5	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Mimics constitutively phosphorylated form and has the ability to interact with CD2AP and CIN85/SH3KBP1 without EGF treatment. Y->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16895919;Dbxref=PMID:16895919	
Q96EY5	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Abolishes interaction with CD2AP and CIN85/SH3KBP1. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16895919;Dbxref=PMID:16895919	
